Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–6
Headlines
6
Sources here
1
Companies here
4
Current section Austria Medical Devices news
Latest

finance.yahoo.com Earnings

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards Lifesciences Corporation EW shares have gained 14% in the past three months as growth across its structural-heart franchises has strengthened the operating case. Second-quarter results showed double-digit expansion in transcatheter aortic valve replacement and faster growth in transcatheter mitral and tricuspid therapies. The rally leaves investors balancing broader growth and raised 2026 expectations against a valuation that …

Main company 🇦🇹 Austria
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup negative 43.7% EWLS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Main company 🇦🇹 Austria

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -15.8% · Next-week setup positive 55.8% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

DXCM main company
Sharemaestro market context Trend signal active 52 weeks +4.8% DXCM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Provider-linked mention 🇦🇹 Austria

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

ZBH mentioned
Sharemaestro market context Trend signal started 52 weeks -3.8% ZBH stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇦🇹 Austria

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -15.8% · Next-week setup positive 55.8% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇹 Austria

Zimmer Biomet Q2 Earnings Call Highlights

Key Points Interested in Zimmer Biomet Holdings, Inc.? Here are five stocks we like better. Zimmer Biomet reported solid Q2 growth: Net sales rose 4.8% to $2.177 billion, driven by hips, specialty businesses and technology. Adjusted EPS was $2.07, while U.S. organic sales increased …

ZBH main company
Sharemaestro market context Trend signal started 52 weeks -3.8% ZBH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context